AC2993 LARGoal: Sustained-Release Treatment for Type 2 Diabetes
Unique opportunity for long-acting sustained release
- Glucose dependent actions
- Extremely potent with long half-life
Working with Alkermes on various sustained-releaseformulations
Continuous Infusion of AC2993
AC2993 reaches steady state